New Findings in Molecular and Structural Properties of IL-23 Inhibitors: A Breakthrough in Psoriasis TreatmentÂ
Biologics that inhibit the pro-inflammatory cytokine IL-23 have long been regarded as important therapies in the treatment of psoriasis. However, much is still unknown about the molecular mechanisms that drive clinical efficacy. In this study, researchers sought to uncover the key driving factors by analyzing several IL-23 inhibitors in the treatment of psoriasis. Their findings, […]
